Murine models of drug hypersensitivity

Current Opinion in Allergy and Clinical Immunology

Volumn 5, Issue 4, 2005, Pages 331-335

  Nierkens, Stefan ^a,b   Pieters, Raymond ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Animal models; Drug hypersensitivity; Mechanisms; Predictive screening

Indexed keywords

ANTINUCLEAR ANTIBODY; AUROTHIOMALATE; B7 ANTIGEN; CD28 ANTIGEN; CD4 ANTIGEN; CD40 ANTIGEN; CD40 LIGAND; CD86 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; EPITOPE; GOLD; HAPTEN; HYDROXYLAMINE; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G1 ANTIBODY; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 10; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 4; LIPOPOLYSACCHARIDE; NUCLEOPROTEIN; PENICILLAMINE; POLYRIBONUCLEOTIDE; PROCAINAMIDE; TACROLIMUS; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TRANSCRIPTION FACTOR; TRANSFORMING GROWTH FACTOR BETA; UNINDEXED DRUG;

ANTIGEN PRESENTING CELL; ANTIGEN RECOGNITION; AUTOIMMUNITY; CROSS REACTION; CYTOKINE PRODUCTION; DRUG HYPERSENSITIVITY; DRUG SCREENING; EXPERIMENTAL MODEL; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; IMMUNOSTIMULATION; MORBIDITY; MORTALITY; NONHUMAN; PARAMETER; PATHOPHYSIOLOGY; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SENSITIZATION; SIGNAL TRANSDUCTION; SYMPTOM; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION;

EID: 22544473360     PISSN: 15284050     EISSN: 14736322     Source Type: Journal    
DOI: 10.1097/01.all.0000173786.88648.1d     Document Type: Review

References (35)

1. Demoly P, Bousquet J. Epidemiology of drug allergy. Curr Opin Allergy Clin Immunol 2001; 1:305-310.
2. Dean JH. The nature and importance of drug allergy [abstract]. Toxicology 2000; 148:11-12.
3. Shenton JM, Chen J, Uetrecht JP. Animal models of idiosyncratic drug reactions. Chem Biol Interact 2004; 150:53-70. This summarizes existing models of idiosyncratic drug reactions and states criteria for viable animal models.
4. Griem P, Wulferink M, Sachs B, et al. Allergic and autoimmune reactions to xenobiotics: how do they arise? Immunol Today 1998; 19:133-141.
5. Pichler WJ. Drug-induced autoimmunity. Curr Opin Allergy Clin Immunol 2003; 3:249-253.
6. Seguin B, Uetrecht J. The danger hypothesis applied to idiosyncratic drug reactions. Curr Opin Allergy Clin Immunol 2003; 3:235-242.
7. Layland LE, Wulferink M, Dierkes S, Gleichmann E. Drug-induced autoantibody formation in mice: triggering by primed CD4+CD25- T cells, prevention by primed CD4+CD25+ T cells. Eur J Immunol 2004; 34:36-46. This article describes the significance of regulatory CD44-CD25+ T cells in drug-induced autoimmunity and provides experimental evidence for epitope spreading.
8. Rubin RL, Kretz-Rommel A. Initiation of autoimmunity by a reactive metabolite of a lupus-inducing drug in the thymus. Environ Health Perspect 1999; 107 (Suppl 5):803-806.
9. Goebel C, Kubicka-Muranyi M, Tonn T, et al. Phagocytes render chemicals immunogenic: oxidation of gold(I) to the T cell-sensitizing gold(III) metabolite generated by mononuclear phagocytes. Arch Toxicol 1995; 69:450-459.
10. Donker AJ, Venuto RC, Vladutiu AO, et al. Effects of prolonged administration of D-penicillamine or captopril in various strains of rats. Brown Norway rats treated with D-penicillamine develop autoantibodies, circulating immune complexes, and disseminated intravascular coagulation. Clin Immunol Immunopathol 1984; 30:142-155.
11. Masson MJ, Uetrecht JP. Tolerance induced by low dose D-penicillamine in the brown Norway rat model of drug-induced autoimmunity is immune-mediated. Chem Res Toxicol 2004; 17:82-94. The investigators demonstrate the role of macrophages and T cells in the induction of oral tolerance to D-Pen-induced autoimmunity, and show the reversal of tolerance by LPS or poly I:C in a dose-dependent manner.
12. Seguin B, Masson MJ, Uetrecht J. D-penicillamine-induced autoimmunity in the Brown Norway rat: role for both T and non-T splenocytes in adoptive transfer of tolerance. Chem Res Toxicol 2004; 17:1299-1302. This study showed that transferred tolerant splenocytes are unable to completely prevent D-Pen-induced autoimmunity.
13. Masson MJ, Teranishi M, Shenton JM, Uetrecht J. Investigation of the involvement of macrophages and T cells in D-penicillamine-induced autoimmunity in the Brown Norway rat. J Immunotoxicol 2004; 1:79-93. The authors show that tacrolimus prevented and reversed ongoing autoimmune disease and suggests that CD86+ APC in the caecum may be important in the induction of disease.
14. Gruchalla RS. Drug metabolism, danger signals, and drug-induced hypersensitivity. J Allergy Clin Immunol 2001; 108:475-488.
15. Pirmohamed M, Naisbitt DJ, Gordon F, Park BK. The danger hypothesis: potential role in idiosyncratic drug reactions. Toxicology 2002; 181-182:55-63.
16. Nierkens S, van Helden P, Bol M, et al. Selective requirement for CD40-CD154 in drug-induced type 1 versus type 2 responses to trinitrophenyl-ovalbumin. J Immunol 2002; 168:3747-3754.
17. Gruchalla RS. 10. Drug allergy. J Allergy Clin Immunol 2003; 111:S548-S559.
18. Hizawa N, Yamaguchi E, Jinushi E, et al. Increased total serum IgE levels in patients with asthma and promoter polymorphisms at CTLA4 and FCER1B. J Allergy Clin Immunol 2001; 108:74-79.
19. Lee SY, Lee YH, Shin C, et al. Association of asthma severity and bronchial hyperresponsiveness with a polymorphism in the cytotoxic T-lymphocyte antigen-4 gene. Chest 2002; 122:171-176.
20. Ueda H, Howson JM, Esposito L, et al. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 2003; 423:506-511.
21. Immunotoxicology Technical Committee. Application of flow cytometry to immunotoxicity testing: summary of a workshop. Toxicology 2001; 163:39-48.
22. Pieters R, Ezendam J, Bleumink R, et al. Predictive testing for autoimmunity. Toxicol Lett 2002; 127:83-91.
23. Descotes J. Autoimmunity and toxicity testing. Toxicol Lett 2000; 112-113:461-465.
24. Ravel G, Christ M, Horand F, Descotes J. Cytokine release does not improve the sensitivity and specificity of the direct popliteal lymph node assay. Toxicology 2004; 200:247-254.
25. Popovic M, Nierkens S, Pieters R, Uetrecht J. Investigating the role of 2-phenylpropenal in felbamate-induced idiosyncratic drug reactions. Chem Res Toxicol 2004; 17:1568-1576. The authors describe that the felbamate metabolite 2-phenylpropenal is a potent immunogen and may therefore be involved in felbamate-induced autoimmune disorders.
26. Nierkens S, Nieuwenhuijsen L, Thomas M, Pieters R. Evaluation of the use of reporter antigens in an auricular lymph node assay to assess the immunosensitizing potential of drugs. Toxicol Sci 2004; 79:90-97. It is shown that immunosensitizing drugs can be detected with the reporter antigen approach after injection of the compounds in the footpad or intradermally in the ear.
27. Hopkins JE, Naisbitt DJ, Humphreys N, et al. Exposure of mice to the nitroso metabolite of sulfamethoxazole stimulates interleukin 5 production by CD4(+) T-cells. Toxicology 2005; 206:221-231. The data reported in this article indicate the metabolite of sulphamethoxazole-nitric oxide, and not sulphamethoxazole itself, activates immune responses and that CD4+ cells are the major source of the production of IL-5.
28. Nierkens S, Aalbers M, Bol M, et al. Development of an oral exposure mouse model to predict drug-induced hypersensitivity reactions by using reporter antigens. Toxicol Sci 2005; 83:273-281. A study showing that orally administered drugs stimulate immune responses to an intraperitoneally coinjected bystander antigen. The models presented may help to predict the immune stimulating or sensitizing capacities of drugs.
29. Gutting BW, Updyke LW, Amacher DE. BALB/c mice orally pretreated with diclofenac have augmented and accelerated PLNA responses to diclofenac. Toxicology 2002; 172:217-230.
30. Gutting BW, Bouzahzah F, Kong PL, et al. Oxazolone and diclofenac-induced popliteal lymph node assay reactions are attenuated in mice orally pretreated with the respective compound: potential role for the induction of regulatory mechanisms following enteric administration. Toxicol Appl Pharmacol 2003; 189:120-133.
31. Descotes J. Importance of immunotoxicity in safety assessment: a medical lexicologist's perspective. Toxicol Lett 2004; 149:103-108.
32. Kowalski ML, Ptasinska A, Bienkiewicz B, et al. Differential effects of aspirin and misoprostol on 15-hydroxyeicosatetraenoic acid generation by leukocytes from aspirin-sensitive asthmatic patients. J Allergy Clin Immunol 2003; 112:505-512.
33. Gerber BO, Pichler WJ. Cellular mechanisms of T cell mediated drug hypersensitivity. Curr Opin Immunol 2004; 16:732-737.
34. Snodin DJ. Regulatory immunotoxicology: does the published evidence support mandatory nonclinical immune function screening in drug development? Regul Toxicol Pharmacol 2004; 40:336-355.
35. Olsen NJ. Drug-induced autoimmunity. Best Pract Res Clin Rheumatol 2004; 18:677-688.